Cindy Eckert - Wikipedia

Cindy Eckert is an American entrepreneur known for founding Sprout Pharmaceuticals. She subsequently founded The Pink Ceiling which invests in companies founded by, or delivering products for, women. [1] In November 2017, Eckert re-acquired Sprout Pharmaceuticals as part of a lawsuit settlement, and the rights to its drug Addyi, from Valeant after Valeant's stock collapsed due to insider ...

Cindy Whitehead's $1 Billion Acquisition with Female Viagra - Built To Sell

The Founder of the "Female Viagra" Sells Her Business for $1 Billion ... Cindy Whitehead started Sprout Pharmaceuticals and created the drug ADDYI, which has become known as the "female Viagra". After years of fundraising to finance clinical trials and research, Whitehead finally got ADDYI approved by the Food & Drug Administration (FDA ...

Watch: This CEO Sold Her 'Female Viagra' Startup for $1 Billion. Here's ...

Cindy Eckert, founder of Sprout Pharmaceuticals, discussed her company's journey, tips for building a strong culture, and how she deals with skeptical investors.

Why This Sexual Health Founder's Favorite F-Word Is 'Fortitude'

At SXSW, Cindy Eckert reflects on lessons learned after she took back her company when buyers failed to successfully market her groundbreaking female Viagra.

Why The Woman Behind The So-Called 'Female Viagra' Won't Stop ... - Forbes

Developed by Sprout Pharmaceuticals, Addyi treats low libido—a condition called hypoactive sexual desire disorder (HSDD) that affects 1 in 10 women.Before Addyi made history in 2015 as the first ...

What the Founder Behind 'Female Viagra' Has Learned About Investing ...

Here's a quick summary: Eckert had been the CEO of Sprout Pharmaceuticals, the company behind female libido drug Addyi. She sold the startup to Valeant for $1 billion, sued Valeant for failing ...

Why Valeant Gave Up on the 'Female Viagra' - Fortune

Valeant Pharmaceuticals is giving Addyi, the female libido drug dubbed 'the female Viagra,' back to its former owners. This is quite a big deal as Valeant bought Sprout Pharmaceuticals, the ...